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ABSTRACT 
 
Porcine Fructose-1,6-bisphosphatase is a homotetramer with four identical subunits. 
It plays a central role in gluconeogenesis and is tightly regulated by metabolites fructose 2,6-
bisphosphate (F26P2) and AMP. Loop 52-72, loop 182-194 and residues 7-11 of the N-
terminal segment play important role in the mechanism of catalysis and allosteric inhibition 
by AMP by retaining a structural hydrophobic region. Disruption of the hydrophobic region 
will evidently affect the catalysis and regulation of FBPase. Mutation of Thr53 reduced the 
catalysis activity of FBPase, mutation of Thr194 eliminated inhibition of AMP due to its low 
affinity to the enzyme, while double mutation Thr53/194 had accumulative effect. Mutation 
Ala10 exhibited biphasic AMP inhibition, an AMP high affinity site which had comparable 
IC50 with wild-type FBPase and an AMP low affinity site which required 3000-fold AMP to 
reach 50% relative inhibition. 
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INTRODUCTION 
 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphophate 1-phosphohydrase, EC 
3.13.11;FBPase) hydrolyzes fructose 1,6-bisphosphate (F16P2) to fructose 6-phosphate (F6P) 
and inorganic phosphate (Pi)(Figure 1)(1-5). The kinetic data of the wild-type enzyme is 
shown in Table 1. FBPase, along with fructose-6-phosphate 1-kinase, define a futile cycle in 
the gluconeogenic/glycolytic pathways (Figure 2)(6,7).  FBPase  plays a central role in 
gluconeogenesis, and is tightly regulated by metabolites fructose 2,6-bisphosphate (F26P2) 
and AMP, both of which inhibit FBPase, while simultaneously activating fructose-6-
phosphate 1-kinase(Figure 3)(5,7). FBPase requires divalent cations (Mg2+,  Mn2+,  and/or 
Zn2+) for activity, and certain monovalent cations (K+, NH4+, and Tl+) further enhance 
catalysis(3,4). The divalent cation Mg2+ sigmoidally increases enzyme activity at pH 7.5 with 
a Hill coefficient of approximate 2; however, the effect is hyperbolic at pH 9.6(8,9). AMP, 
binding to an allosteric site, inhibits FBPase with a Hill coefficient of 2 (8,10).  F26P2  
biosynthesis and degradation is subject to hormonal control principally by glucagon and 
insulin (7,11), inhibits FBPase by direct ligation at the active site with a Hill coefficient of 
unity(3-5).  Inhibition of FBPase by AMP is nonlinear and noncompetitive with respect to 
F16P2, but nonlinear and competitive with respect to  essential cations (Mg2+,  Mn2+,  or 
Zn2+)  (12,13).  In contrast, inhibition of FBPase by F26P2 is linear and competitive with 
respect to F16P2 but noncompetitive with respect to Mg2+ and synergistic with AMP. F26P2 
can lower the apparent inhibition constant for AMP up to 10-fold by enhancing the binding 
of AMP to FBPase (14). Because the concentration of AMP in vivo is relatively constant, the 
inhibitory effect of AMP will vary with respect to F26P2 levels.   
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FBPase is a homotetramer with four identical subunits (Mr = 37,000) (Figure 4). Each 
subunit has binding sites for F16P2, F26P2, and metal ions, which taken together define the 
active site, and a distinct allosteric  AMP binding site (12,15,16).  The closest distance 
between the AMP binding site and the active site is 28 Å in the same subunit. The four 
subunits of the tetramer occupy the corners of a rectangle, labeled clockwise: C1 through C4, 
starting with the upper right-hand corner subunit(17).  FBPase exists in at least two distinct 
conformational states, called R (active) and T (inactive). In the R-state, the four subunits lie 
in the same plane. Binding of AMP to the allosteric site of FBPase causes a transition from 
the active R-state to inactive T-state by driving a 17o rotation of the C1-C2 subunit pair with 
respect to the C3-C4 subunit pair (17,18) (Figure 5). Recent studies revealed two 
intermediate or hybrid conformations, R-like (IR-state) (Figure 6) (19) and T-like (IT-state) 
(Figure 7) (20). An understanding of the transition between these hybride states may clarify 
the mechanism of the conformational changes that occur between the canonical R and T-
States. 
A region of FBPase known as the “dynamic loop 52-72”  plays an important role in 
the allosteric transition of AMP inhibition, having been observed in three conformational 
states, engaged, disengaged, and disordered (21).  The engaged conformation exists in metal-
product complexes of wild-type FBPase in the absence of AMP, in which loop 52-72 
interacts with the active site (22-24). The disengaged confirmation occurs in AMP complexes 
with or without products, in which the disengaged loop is far removed from the active 
site(22,25). The binding of AMP to its allosteric pocket putatively displaces the loop from 
the active site, and stabilizes the disengaged loop conformation.  The disordered 
conformations of the dynamic loop have appeared in both the R- and T-states, in which the 
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loop itself interacts weakly with the rest of the enzyme (19,26,27). Mutations of conserved 
residues in loop 52-72 have significant effects on catalysis and allosteric inhibition of 
catalysis by AMP (28,29). 
Studies on the dynamic loop 52-72 have revealed its potential on the research of the 
quaternary transition of FBPase. The mechanism of confirmational change between R-state 
and T-state of FBPase was elusive until recent studies which revealed the first intermediate 
state of porcine FBPase: a T-like conformation due to the binding of an allosteric effector to 
the center of the tetramer(Figure 7)(20). The results of that study increase the likelihood of 
finding intermediate conformational states of FBPase by crystallization and x-ray diffraction 
analysis.  The study of mutant Ala54→Leu revealed an R-like intermediate conformation (IR) 
of FBPase in the presence of AMP (Figure 6)(19). In the presence of AMP, the Leu54 enzyme 
grows in two crystal forms: a T-like conformation which has a disordered dynamic loop and 
an R-like conformation which has an engaged dynamic loop. In this case, the conformation 
of the key packing interaction of the disengaged loop 52-72 is disrupted by the mutation of 
Ala54→Leu in the presence of saturating AMP. The Leu54 enzyme has wild-type catalytic 
properties and retains cooperativity in AMP inhibition but exhibits a 50-fold increase in the 
IC50 for AMP (19). In the IR-state, the dihedral angle of subunit pair C1-C2 relative to C3-C4 
is 3o, which is between that of the canonical R-state (0o rotation) and T-state (15o rotation) 
and differs from the IT-state (9o)  (Figure 8)(19). The IR structure presents the immediate 
consequences of AMP association in the absence of an allosteric transition and reveals the 
effect of AMP binding in the absence of a complete quaternary transition. These findings 
suggest the mechanism by which AMP leverages the allosteric transition in FBPase. 
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It is well established that the T-state and R-state of structures of FBPase differ by a 
17° rotation about a molecular symmetry axis (22). In addition, the subunits in the T- and R-
states can adopt different tertiary conformations. The loop 52-72 plays significant role in the 
confirmational changes. In the R-state conformation, loop 52–72 occupies an engaged 
conformation or a disordered conformation. In 1989, Ke et al. reported the disordered 
conformation of loop 52–72 in FBPase structures crystallized in the absence of metal 
activators (30).  Choe et al later observed the engaged conformation in the context of a 
product-Zn2+ complex of the wild-type enzyme (31). In the T-state of wild-type FBPase, loop 
52–72 is in the disengaged conformation and is stabilized by the interactions among T-state 
FBPase subunits. These interactions involve residues 50–60 of subunit C1 with residues 187–
194 and 9–11 of subunit C2 (Figure 9) (21). Point mutations in these structural elements 
profoundly influence AMP inhibition (32,33), AMP cooperativity (33,34), F26P2 inhibition 
(32,34), and/or metal affinity (32).  
A model for allosteric regulation of AMP inhibition was proposed in 2001 (21). At 
neutral pH, catalysis will occur if loop 52–72 can cycle between its engaged and disordered 
conformations. A loop that is always engaged is a dead-end complex. A loop that cannot 
achieve the engaged conformation results in low metal affinity and little or no activity at 
neutral pH. Assuming loop 52–72 exchanges between its engaged and disordered 
conformations, the free energy differences between these conformational states must be 
small, that is, the R-state maintains small free-energy differences between disordered and 
engaged conformations of loop 52–72. In contrast, the T-state subunit arrangement 
selectively stabilizes a new conformation for loop 52–72 (disengaged conformation), which 
depopulates the disordered/ engaged loop conformations. The decline in the catalytic rate of 
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T-state FBPase is directly related to the differences in free energy between the 
engaged/disordered loop conformations and the disengaged loop conformation. For the wild-
type enzyme, the free energy difference is large; hence, little or no catalysis occurs. I the case 
of specific mutants of FBPase that selectively destabilize the disengaged loop conformation, 
the less the free energy difference, the more populated the engaged/disordered loop 
conformations are. As a consequence, a measurable level of catalysis occurs. Here, the 
activity may come from FBPase in the T-state subunit arrangement. The free energy 
relationships of the model are summarized in Figure 10 (21).  
Recent studies on the Ile10→Asp FBPase revealed that FBPase activity may come 
from the IT-state (unpublished paper), in which loop 52-72 adopts the engaged conformation.  
If the dynamic loop cannot form the disengaged conformation due to mutation, then the free-
energy levels of the IT- and T-states may be nearly equal, resulting in substantial activity in 
the presence of saturating AMP. The mechanism of maintaining the conformation of the 
dynamic loop in the engaged conformation in the T-state or IT-state is still unknown. 
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EXPERIMENTAL PROCEDURES 
 
Materials ⎯ F16P2, F26P2, NADP+, and AMP were purchased from Sigma. DNA-modifying 
and restriction enzymes and T4 polynucleotide kinase, and ligase were from Promega. 
Glucose-6-phophate dehydrogenase and phosphoglucose isomerase came from Roche 
Applied Sciences. Cibracon Blue sepharose resin, DEAE sepharose resin, and G-50 resin 
were purchased from Sigma. Other chemicals were of reagent grade or equivalent. 
Escherichia coli strains BMH 71-18 mutS and XL1-Blue came from Clontech and 
Stratagene, respectively. The FBPase-deficient E. coli strain DF657 came from the Genetic 
Stock Center at Yale University. 
 
Instruments ⎯ Sorvall RC-5B refrigerated superspeed centrifuge (Du Pont Instruments), 
Sorvall Biofuge Pico centrifuge (Knedro Laboratory Products), SLM 8100C fluorimeter 
(Spectronic Instruments), CARY 100 Bio UV-Visible spectrophotometer (Varian Analytical 
Instruments), iCycle Thermal cycler (Bio-Rad), Accumet pH meter 915 (Fisher Scientific). 
 
Mutagenesis of Wild-Type FBPase ⎯ Mutations were accomplished by specific base 
changes in double-stranded plasmid using the TransformerTM site-directed mutagenesis kit 
(Clontech). The mutagenic primers are as follows: 
Thr39→Val: 5’-GCTCAACTCGCTGTGCGTCGCGGTCAAAGCC- 3’ 
5’-GGCTTTGACCGCGACGCACAGCGAGTTGAGC- 3’ 
Thr39→Ile: 5’-GCTCAACTCGCTGTGCATCGCGGTCAAAGCC- 3’ 
5’-GGCTTTGACCGCGATGCACAGCGAGTTGAGC- 3’ 
Ile194→Thr: 5’-ATCGGAGAGTTCACTTTGGTGGACAGGGAT- 3’ 
5’-ATCCCTGTCCACCAAAGTGAACTCTCCGAT- 3’ 
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Ile53→Thr: 5’-AAGGCGGGCACCGCGCACCTCTATGGAATT- 3’ 
5’-AATTCCATAGAGGTGCGCGGTGCCCGCCTT- 3’ 
Ile53→Val: 5’-AAGGCGGGCGTCGCGCACCTCTATGGAATT- 3’ 
5’-AATTCCATAGAGGTGCGCGACGCCCGCCTT- 3’ 
Ile194→Val: 5’-CGGAGAGTTCGTTTTGGTGGACAGGG- 3’ 
5’-CCCTGTCCACCAAAACGAACTCTCCG- 3’ 
Thr66→Gly: 5’-TCCACGAACGTGGGAGGTGATCAAGTGAAG- 3’ 
5’-CTTCACTTGATCACCTCCCACGTTCGTGGA- 3’ 
Ile53→Ala: 5’-CAAGGCGGGCGCCGCGCACCTCTATGGAATT- 3’ 
5’-AATTCCATAGAGGTGCGCGGCGCCCGCCTTG- 3’ 
Ile10→Ala: 5’-CGACACCAATGCCGTCACCCTAACCCGC- 3’ 
5’-GCGGGTTAGGGTGACGGCATTGGTGTCG- 3’ 
Ile194→Ala: 5’-CGGAGAGTTCGCTTTGGTGGACAGGG- 3’ 
5’-CCCTGTCCACCAAAGCGAACTCTCCG- 3’ 
 
(codons for point mutations are underlined in bold typeface) 
Mutations and the integrity of the construct were confirmed by sequencing the promoter 
region and the entire open reading frame.  The Iowa State University sequencing facility 
provided DNA sequences, using the fluorescent dye-dideoxy terminator method. 
 
Expression and Purification Wild-type and FBPase Mutants⎯  Effective protein expression 
and purification procedures for wild-type and FBPase mutants have been developed (19) and 
are described below. To avoid contamination of recombinant FBPase by endogenous 
enzyme, an FBPase-deficient strain of E.coli (DF657) is always used in the expression of the 
enzymes. The culture is collected by centrifuging after growing overnight at 37o C following 
IPTG inducing when cell density (OD600) reaches 1.0~1.2. Large volumes of cells are broken 
by the method of the French Press, while small amounts were lysed by sonication. Cell-free 
extracts of FBPase are subjected to heat treatment (usually 65o C for 5 minutes, temperature 
and/or time length might be changed depending on different mutant proteins), followed by 
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centrifugation.  This has been shown to be an effective procedure for rapidly and easily 
eliminating most contaminating proteins with little loss of FBPase catalytic activity. The 
supernatant solution is then loaded onto a Cibracon Blue sepharose column which had 
previously been equilibrated with 20 mM Tris-HCl (pH 7.5) + 5 mM MgCl2.  The column is 
then washed with 20 mM Tris-HCl pH 7.5 buffer.  Then, enzyme is eluted with a solution of 
500 mM NaCl in 20 mM Tris-HCl of the same pH.  The protein sample is then subjected to 
desalting and pH adjustment by applying it to a G-50 column that had been washed with 20 
mM Tris-HCl pH 8.3 buffer. The protein sample is then loaded onto a DEAE sepharose 
column equilibrated with the same buffer.  Purified enzyme is eluted by NaCl gradient (0–0.6 
M) in 20 mM Tris-HCl pH 8.3, and then applied again to a G-50 column pre-equilibrated by 
20 mM Tris-HCl pH 7.5 buffer for desalting and pH adjustment.  Purity and protein 
concentrations of FBPase preparations are subject to be confirmed by SDS-polyacrylamide 
gel electrophoresis (35) and the Bradford assay (36), respectively. The purity of FBPase 
preparation is usually 95% or greater.  
 
Kinetic Experiments—Assays for the determination of kcat and specific activity ratios at pH 
7.5/9.5 employ the coupling enzymes, phosphoglucose isomerase, and glucose-6-phosphate 
dehydrogenase (3). The reduction of NADP+ to NADPH was monitored by absorbance at 
340nm. Other kinetic assays use the same coupling enzymes but monitored the formation of 
NADPH by its fluorescence emission at 470 nm using an excitation wavelength of 340 nm. 
Assays are performed at 22 °C in 50 mM Hepes pH 7.5, or in 50 mM CAPS pH 9.5. Assay 
solutions contain EDTA and KCl at concentrations of 10 µM and 150 mM, respectively. 
Initial rates is analyzed with programs written either in MINITAB using an α value of 2.0 
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(13) or by ENZFITTER (37). The kinetic data for AMP inhibition with respect to Mg2+ and 
F26P2 inhibition with respect to F16P2 were fit to several models, and the parameters 
associated with the best-fitting models of inhibition are reported below. 
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RESULTS 
 
Expression and Purification Wild-type and FBPase Mutants⎯Expression and isolation 
procedures described in ‘Experimental Procedures’ provided wild-type and most FBPase 
mutants at 95% or greater purity as  judged by SDS-polyacrylamide gel electrophoresis. 
Usually, FBPase protein (wild-type or mutant) can be specifically eluted by 20mM Tris-HCl  
pH 7.5 buffer + 5mM AMP after loading to the Cibracon Blue sepharose column. For some 
mutants (those with very high Ki values for AMP, the AMP elution is not satisfactory), 0.5M 
NaCl in 20mM Tris-HCl  pH 7.5 buffer was used. Subsequent to this step in the purification 
procedure, a G-50 column for desalting and AMP removal is required.  At pH 8.3, the 
FBPase protein (wild-type or mutant) binds to DEAE sepharose resins weakly. Protein was 
eluted at the immediately after the NaCl gradient was initiated; however, some mutant 
proteins did not bind to the resins. In these cases, a flow-through sample after protein loading 
and/or a 20mM Tris-HCl pH 8.3 (w/o salt) sample was collected. Figure 11 and Figure 12 
show the purification procedure of FBPase I53T (which bound to the DEAE sepharose resin) 
and I194T (which did not bind to the DEAE sepharose resins), respectively. Both SDS-
polyacrylamide gels indicated no proteolysis of the purified enzymes. 
 
Kinetic Experiments⎯Kinetic parameters for wild-type FBPase are depicted in Table 1. 
Initial rate kinetic studies employed substrate concentrations saturating with respect to F16P2 
(20 µM) and Mg2+ (10 times Ka-Mg2+) but not so high as to cause inhibition. Mutants involve 
alterations in the dynamic loop (loop 52-72), loop 185-194, and the N-terminal segment of 
recombinant porcine FBPase, which together compose structural elements important for 
 
11 
 
allosteric regulation of FBPase. 
 
I. Mutations at Ile53 and Ile194 
Kinetic data for mutant FBPases at residue(s) Ile53 and/or Ile194 are shown in Table 2. 
Mutations at residue(s) Ile53 and/or Ile194 have a decreased turnover number relative to wild-
type FBPase. Maximal reduction of kcat occurred when Isoleucine53 was mutated to 
Threonine (5-fold lower relative to wild-type FBPase). Though the ratio of specific activities 
at pH 7.5 and 9.5 for I53T FBPase is low, the low value does not arise from the proteolysis of 
that mutant (Figure 11). Other mutants have pH ratios comparable to that of wild-type 
FBPase indicating that they are free of proteolysis. In addition, this finding is consistent with 
results from SDS-polyacrylamide gel electrophoresis (data not shown).  
The determination of Km for F16P2 (KmF16P2 in Table 2) at pH 7.5 employed a 
saturating concentration of Mg2+  (5.0 mM) and concentrations of F16P2 ranging from 0.5 to 
20 µM. Data were fit to the Michaelis-Menten Equation: 
v/Vm = S/( KmF16P2 + S) 
where v is the velocity, Vm is the maximum velocity at saturating concentrations of F16P2, S 
is the concentration of F16P2, and KmF16P2 is the Michaelis constant for F16P2. The affinity of 
FBPase for F16P2 decreases slightly for mutant I53T, 2-fold lower for I194T, and has an 
accumulative effect for the double mutant, FBPase I53/194T. Valine and alanine mutants 
exhibit no obvious change for Km of F16P2, except of mutant I194A. 
The Hill coefficient for Mg2+ was determined at a saturating, but noninhibiting 
concentration of F16P2 (20 µM) and concentrations of free Mg2+ ranging from 0.1 to 5.0 
mM. Data were fit to Equation 1,  
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v/Vm = 1/ [1 + (A0.5/A)n]                                                          (Eq. 1) 
where v is the velocity, Vm is the maximum velocity at saturating concentrations of F16P2 
and Mg2+, A is the concentration of Mg2+, n is the Hill coefficient for Mg2+, and A0.5 is the 
concentration of Mg2+ that gives v/Vm of 50%. Mutations at positions 53 lost almost half 
affinity of Mg2+, while mutations at positions 194 had no obvious change. All mutants tested 
caused no changes in Mg2+ cooperativity. 
The Hill coefficient for AMP was determined at saturating F16P2 (20 µM), 
concentrations of free Mg2+ at A0.5 of each mutant FBPase, and AMP concentrations ranging 
from 0 to 50 µM for I53T, I53V, I53A, I194V and I194A, 0 to 200 µM for I194T and 
I53/194T. Data were fit to Equation 2, 
v/V0 = 1/[1 + (I/I0.5)n]                                                               (Eq. 2) 
where v is the velocity, V0 is the velocity at an AMP concentration of zero, I is the 
concentration of AMP, n is the Hill coefficient for AMP, and I0.5 is the concentration of AMP 
that gives v/V0 of 50%. Obviously, threonine mutations lowered the affinity of FBPase for 
AMP. The concentrations of AMP that are required for 50% inhibition, increased 5-fold for 
I53T, 40-fold for I194T, and 15-fold for double mutant I53/194T. I0.5 showed a slight 
increase for I194V, I194A and I53A, but a decrease for I53V. All mutants exhibited both 
Mg2+ and AMP cooperativity. 
The kinetic mechanism of AMP inhibition with respect to Mg2+ was determined from 
assays that employed saturating (20 µM) F16P2, five different Mg2+ concentrations, and five 
different AMP concentrations.  Mg2+ concentrations ranged from A0.5 of each mutant FBPase 
to 5.0 mM. AMP concentrations ranged from 0 to 5-fold I0.5 of each mutant FBPase. A model 
for non-linear competitive inhibition (Equation 3) provided the best result (goodness-of-fit of 
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<5%), 
Vm/v=1 + Ka/A2 + (Ka/KiAMP) (I/A)2                                              (Eq. 3) 
where v is the velocity, Vm is the velocity at an inhibitor concentration of zero saturating 
concentrations of F16P2 and Mg2+, A is the concentration of Mg2+, I is the concentration of 
AMP, Ka is the Michaelis constant for Mg2+, and KiAMP is the dissociation constant for AMP 
from the enzyme-inhibitor complex. Equation 3 constrains the Hill coefficients for Mg2+ and 
AMP to 2, consistent with independent determinations of these quantities. These results are 
identical with independent experiment indicating that complete AMP inhibition for threonine 
mutants requires more AMP than for the wild-type enzyme. 
F26P2 is a substrate analog that binds at the active site of the enzyme. The kinetic 
mechanism of F26P2 inhibition with respect to F16P2 was determined from assays that 
employed saturating Mg2+ (5 mM), five different concentrations of F16P2 (ranging from 1 to 
5-time of KmF16P2), and five different concentrations of F26P2  (0–1 µM for I53V and 0–5 µM 
for others). A model for linear competitive inhibition provided the best fit to the data 
(goodness-of-fit of <5%), 
Vm/v=1 + Kb/B + (Kb/KiF26P2) (I/B)                                              (Eq. 4) 
where Vm is the velocity at an inhibitor concentration of zero and saturating concentrations of 
F16P2 and Mg2+, B is the concentration of F16P2, I is the concentration of F26P2, Kb is the 
Michaelis constant for F16P2, and KiF26P2 is the dissociation constant for F26P2 from the 
inhibitor-enzyme complex. The mechanism of F26P2 inhibition is the same for all mutants 
and wild-type FBPase. 
 
II. Ile10→Ala mutant FBPase 
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Kinetic parameters for Ile10→Ala mutant FBPase are depicted in Table 3. AMP 
inhibition for the I10A mutant is biphasic (Figure 13). Complete AMP inhibition of I10A 
requires ~1000-fold more AMP than for the wild-type enzyme. The biphasic curves of the 
I10A mutant exhibited that there existed two AMP affinity sites: a high affinity site and a low 
affinity site. The biphasic curve of the I10A mutant were fit to Equation 5, 
v=A/[1 + ( I/IC50-high) n1] + B/[1 + (I/IC50-low)n2]                            (Eq. 5) 
where v is the velocity, A and B respectively represent the percentage of high and low 
affinity sites contribution to the inhibition of enzymatic activity, I is the concentration of 
AMP, IC50-high and IC50-low respectively represent concentrations of AMP that cause 50% 
relative inhibition due to the ligation of high and low affinity sites, n1 and n2 are Hill 
coefficients for the high and low affinity sites, respectively. The high affinity site contributed 
84% to the inhibition of enzymatic activity and the low affinity contributed 16%. 
Concentration of AMP that cause 50% relative inhibition due to the ligation of high affinity 
site (IC50-high) was 0.82±0.02 µM with Hill coefficient 1.45±0.03. IC50-low was 3070±403µM 
with Hill coefficient 0.73±0.09. IC50-high of mutant I10A is comparable with the IC50 of wild 
type FBPase, while IC50-low is 3000-fold higher than the IC50 of wild type FBPase. 
Elimination of the high affinity AMP site causes the enzyme to lose its cooperative.  
The kinetic mechanism of AMP inhibition with respect to Mg2+ was determined from 
assays that employed saturating (20 µM) F16P2 at five different Mg2+ concentrations, and 
five different AMP concentrations.  Mg2+ concentrations ranged from 1.0 to 5.0 mM. AMP 
concentrations ranged from 0 to 10 µM. When AMP is absence, the Mg2+ is shown as 
cooperative (Figure 14-A) with a Hill coefficient of 2; whereas by the presence of AMP, the 
cooperativity of Mg2+ is eliminating, and Hill coefficient of Mg2+ is 1 when the concentration 
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AMP presented at 10 µM (Figure 14-B). The loss of Mg2+ cooperativity had been observed 
previously in a 10DEL mutant(21) which appeared a similar biphasic curve with respect of 
AMP inhibition. The kinetic mechanism of F26P2 inhibition with respect to F16P2 is linear 
competitive. 
In the absence of AMP, the Hill coefficient for Mg2+ is approximately 2 (Table 3); 
however, when AMP is bound to FBPase, Mg2+ binding loses its cooperativity (Figure 14). 
These findings suggest that in the case of the Ile10→Ala mutation communication between 
subunits (cooperativity) is lost. An additional consequence of AMP binding to the enzyme is 
the intrasubunit loss of Mg2+ cooperativity. 
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DISCUSSION 
 
Crystal structures of wild-type and various FBPase mutants have shown that loop 52-
72 plays a significant role in the function of FBPase. It is for this reason that investigations of 
this dynamic loop have been a focus of intense research (21-25). Most recently, the discovery 
of an R-like conformation in the presence of saturating AMP has attracted attention (19). In 
the presence of saturating AMP, Leu54→Ala mutant FBPase grew in two crystal forms: a T-
like conformation with a disordered dynamic loop and an R-like confirmation with an 
engaged dynamic loop. This intermediate conformation could be the initial step of the 
quaternary transition of FBPase induced by AMP. In the R-state of FBPase, as shown in 
Figure 15, residues near the hinge of the engaged dynamic loop in subunit C4, loop 182-194 
of subunit C3, and residues 7-11 of the N-terminal segment preceding helix H1 of subunit 
C3, tightly pack together composing a sandwich model. The hydrophobic side chains at 
position 53 and 194 are critical to the stability of the engaged conformation of loop 52-72 in 
the R-state, and thus the catalysis function of FBPase.  
The pH-activity ratio of the Thr53 mutant is lower than that of the wild-type enzyme. 
Usually the low pH ratio is considered to be the criterion of FBPase proteolysis i.e., the 
truncation of 25 residues from the N terminal (38) and/or the proteolysis of loop 52-72 (39). 
However, the results from SDS-polyacrylamide gel electrophoresis of the pure Thr53 enzyme 
did not exhibit any evidence of enzyme proteolysis. Instead, the 5-fold decrease in kcat 
indicates that it may be difficult for loop 52-72 to achieve an engaged conformation in the R-
state of the Thr53 construct.  The lower pH-activity ratio effect was also observed with other 
mutant FBPases (21,32). The effects of the Thr53 mutant can be explained by the importance 
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of the hydrophobic packing shown on Figure 15. The mutation of Ile53 to threonine disrupted 
the hydrophobic environment in the packing sandwich model which is important to the 
stability of the engaged confirmation of loop 52-72 in the R-state. Other mutants at position 
53, which did not change the hydrophobic packing, are essentially identical to wild-type 
FBPase. 
Unlike the Thr53 mutant, the Thr194 mutant significantly alters the AMP allosteric 
regulation of FBPase. Although there was 5-fold increase of KiAMP for the Thr53 mutant, 
mutant Thr194 elevated the KiAMP approximately 1000-fold relative to wild-type FBPase. As 
shown on Figure 9, the hydrophobic space which is composed of Ile10, Ile59, and Ile194 is 
important for stabilization of the disengaged confirmation of loop 52-72 in T-state of 
FBPase. The mutation Ile194 to threonine disrupts the hydrophobic environment and in so 
doing destabilizes the disengaged confirmation of the dynamic loop which ultimately reduces 
the affinity of the enzyme for AMP. Compared with Ile194, residue Ile53 has less effect on 
allosteric inhibition by AMP. Without causing disruption of the hydrophobic environment, 
mutant I194V has no obvious effect on the affinity the enzyme for AMP. As expected, the 
double mutant Ile53/194Thr has complex effects on FBPase properties, i.e., the low pH-
activity ratio might originate from the residue 53 and a decrease on the AMP affinity could 
well stem from residue 194. 
Although residues 10 and 194 both play important role in allosteric regulation in the 
T-state FBPase, they have different effects on the affinity of the enzyme for AMP. While the 
I194T mutant requires much more AMP to reach 50% inhibition relative to wild-type 
FBPase, this is not the case with the I10A mutant.  Mutant I10A reveals biphasic AMP 
inhibition (Fig. 13). The IC50-high of the I10A mutant is comparable to that of wild-type 
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FBPase, but 1000-fold more AMP is required to completely inhibit the catalytic activity of 
FBPase relative to that of the wild-type enzyme. 
As proposed in an earlier report (21), the change between engaged and disordered 
conformations of loop 52-72 is a major aspect of FBPase catalysis. If a mutant selectively 
decreases the stability of the disengaged loop conformation in the T-state, the 
engaged/disordered conformation ratio may increase and a measurable level of catalysis 
could be observed in T-state of FBPase. Mutant FBPases with biphasic AMP inhibition have 
this potential.  As noted above, the hydrophobic side chain at these positions is critical to the 
stability of the disengaged conformation of loop 52-72 in the T-state. Mutant I10D exhibited 
biphasic AMP inhibition and the crystal structure of its AMP/Zn2+ complexes provided an 
engaged dynamic loop in a T-like quaternary state (unpublished data). That is the first 
example of an engaged dynamic loop in a T-like quaternary state. The I10A mutant, which 
exhibited biphasic AMP inhibition identical to that observed with the I10D mutant, could 
have a conformation similar to that of the I10D mutant, i.e., an engaged dynamic loop in the 
presence of AMP which could be in a T-like state or in a canonical T-state. 
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GENERAL CONCLUSIONS 
 
The work described in this thesis contributes to understanding the allosteric 
regulatory mechanism of Porcine Fructose-1,6-bisphosphatase. The kinetic characterization 
of mutant FBPases in residues 53 and 194 revealed two important structural information of 
the regulatory mechanism of FBPase. First, the hydrophobic side chains at position 53 and 
194 are critical to the stability of the engaged conformation of loop 52-72 in the R-state, and 
thus the catalysis function of FBPase. Second, the hydrophobic environment established by 
residue 10, 59, and 194 in the presence of AMP are critical to the AMP allosteric regulation 
of FBPase. The dynamic loop of 52-72 plays an important role on the allosteric regulation of 
FBPase, so lot of works have been done within this region. However, loop 182-194 and 
residues 7-11 of the N-terminal segment also involve into the allosteric regulation of FBPase 
by retaining hydrophobic environment both in R-state and T-state of FBPase. Disruptions of 
the hydrophobic environment have important effects on the catalytic and/or regulatory 
properties of FBPase. Replacing the hydrophobic residue isoleucine to a hydrophilic residue 
threonine at position 53 and/or 194 disrupted the hydrophobic sandwich structure of FBPase 
in the absence of AMP, and thereby reduced the catalytic activity of FBPase. Mutant 
Ile194→Thr further affected the AMP affinity by disrupting the hydrophobic pocket 
composed by residues Ile10, Ile59, Ile194 in the presence of AMP. Double mutant 
Ile53/194→Thr had accumulative effect. Further work on crystallography of these mutants will 
be an important advance and should exhibit us more valuable information and detail. Also we 
can expect that disrupting the hydrophobic pocket by mutating Ile59 should reveal similar 
phenomenon. 
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Residue 10 also plays important role in allosteric regulation in the T-state FBPase, but 
it has different effect on the AMP affinity with residue 194. Ile10→Ala mutant FBPase 
revealed biphasic AMP inhibition, which is identical with other mutants done so far in 
residue 10, indicating that residue 10 plays important role on the communication of AMP 
binding to FBPase. In high affinity site of Ile10→Ala mutant FBPase, the IC50 of AMP to the 
enzyme is comparable to that of wild-type FBPase; while 3000-fold low in the low affinity 
site. Meanwhile, mutant I10A lost its AMP cooperativity. Noticeably, Mg2+ cooperativity 
was also eliminated when both AMP and Mg2+ were present simultaneously, although Mg2+ 
exhibited cooperative in the absence of AMP. This phenomenon could be a consequence of 
the intrasubunit loss of Mg2+ cooperativity when AMP binding to the enzyme and need 
additional work to support. 
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Figure 1. Schematic of the reaction FBPase catalyzes. 
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Table 1. Kinetic parameters for wild-type FBPase.  
 Wild type 
Activity ratio, pH 7.5:9.5 3.2 ±0.1 
kcat (s-1) 20.5±0.6 
KmF16P2 (µM) 1.39±0.11 
A0.5 (mM) 0.90±0.04 
Hill coefficient Mg2+ 1.82±0.16 
I0.5 (µM) 1.48±0.02 
Hill coefficient AMP 1.90±0.04 
Ka (mM2) 1.31±0.21 
KiAMP (µM2) 1.66±0.29 
Kb (µM) 1.83±0.23 
KiF26P2 (µM) 0.22±0.03 
 
The kinetic mechanism of AMP inhibition with respect to Mg2+ fits a model for non-linear 
competitive inhibition: 
Vm/v=1 + Ka/A2 + (Ka/KiAMP) (I/A)2 
 
The kinetic mechanism of F26P2 inhibition with respect to F16P2 fits a model for linear 
competitive inhibition: 
Vm/v=1 + Kb/B + (Kb/KiF26P2) (I/B) 
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Figure 2. A futile cycle defined by FBPase and fructose-6-phosphate 1-kinase in the 
gluconeogenic/ glycolytic pathways. 
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Figure 3. Regulation of FBPase and PFK-1 by F26P2 and AMP. 
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Figure 4. Schematic of the homotetramer conformation of FBPase. 
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Figure 5. Schematic of the T-state conformation of FBPase. A rotation of the subunit pair 
C1-C2 by 17  as shown transforms the T-state into the R-state conformer. Dotted ovals 
represent ligand binding sites on faces of the tetramer hidden from view. Distances measured 
from atom C-2 of F6P of subunit C2 to atoms C-1' of four bound AMP molecules are 
presented. 
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Figure 6. Overview of the R-like (IR) AMP-product complex of Leu54 FBPase. 
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Figure 7. Overview of the T-like (TR) OC252-FBPase complex. 
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Figure 8. Quaternary states of FBPase. 
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Figure 9. Structural elements important to allosteric regulation in the T-state of 
FBPase. 
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Figure 10. Changes in relative free energy levels of three loop conformations in the R- 
and T-states of wild-type and mutant FBPases. 
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Figure 11. Samples for I53T purification (10% SDS-PAGE). 1. Crude enzyme; 2. After 
heating treatment; 3. Cibracon Blue; 4. DEAE-sepharose; 5. G-50; 6. Bio-Rad Low Range 
marker (97kDa,66,45,31,21.5,14.4). 
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Figure 12. Samples for I194V purification (10% SDS-PAGE). 1. Crude enzyme; 2. After 
heating treatment; 3. Cibracon Blue; 4. DEAE-sepharose; 5. G-50; 6. DEAE flow through; 7. 
DEAE wash out; 8. Bio-Rad Low Range marker (97kDa,66,45,31,21.5,14.4). 
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Table 2. Kinetic parameters for wild-type and mutant FBPase (Ile53 and Ile194).  
 
 Wild type Ile53 - Thr Ile194 - 
Thr 
Ile53/194 - 
Thr 
Ile53 - Val Ile194 - 
Val 
Ile53 - Ala Ile194 - 
Ala 
Activity ratio, 
pH 7.5:9.5 
3.2 ±0.1 1.87±0.04 3.08±0.14 2.02±0.04 3.47±0.14 3.54±0.01 3.50±0.21 2.91 ±0.04 
kcat (s-1) 20.5±0.6 4.40 10.69 10.94±0.04 15.16±0.04 14.03 
±1.48 
9.38±0.18 13.2 ±0.8 
KmF16P2 (µM) 1.39±0.11 1.95±0.19 2.60±0.20 3.41±0.35 1.74±0.17 1.93±0.37 1.73±0.20 2.45±0.32 
A0.5 (mM) 0.90±0.04 1.61±0.08 1.05±0.05 2.30±0.14 1.85±0.14 1.14±0.10 2.30±0.11 1.21±0.07 
Hill coefficient 
Mg2+ 
1.82±0.16 1.78±0.14 2.04±0.17 2.00±0.21 1.7±0.16 1.49±0.15 1.79±0.12 1.91±0.20 
I0.5 (µM) 1.48±0.02 6.13±0.21 58±4 22±3 1.00±0.06 4.04±0.07 3.88±0.13 3.63±0.30 
Hill coefficient 
AMP 
1.90±0.04 2.16±0.15 1.80±0.16 1.41±0.22 1.58±0.11 2.35±0.10 1.98±0.12 1.62±0.19 
Ka (mM2) 1.31±0.21 2.07±0.44 0.76±0.13 1.11±0.61 2.28±0.64 0.37±0.19 1.58±0.60 0.88±0.20 
KiAMP (µM2) 1.66±0.29 8.57±2.26 1152±211 96±52 0.22±0.06 1.31±0.72 1.49±0.57 2.38±0.54 
Kb (µM) 1.83±0.23 2.56±0.16 1.50±0.14 1.45±0.3 1.4±0.2 1.80±0.24 1.41±0.18 2.14±0.18 
KiF26P2 (µM) 0.22±0.03 0.26±0.02 0.47±0.04 1.23±0.09 0.08±0.01 0.22±0.03 0.18±0.02 0.21±0.02 
 
 
The kinetic mechanism of AMP inhibition with respect to Mg2+ fits a model for non-linear competitive inhibition: 
Vm/v=1 + Ka/A2 + (Ka/KiAMP) (I/A)2 
 
The kinetic mechanism of F26P2 inhibition with respect to F16P2 fits a model for linear competitive inhibition: 
Vm/v=1 + Kb/B + (Kb/KiF26P2) (I/B) 
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Table 3. Kinetic parameters for wild-type and mutant FBPase (I10A).  
 
 Wild type Ile10 - Ala 
Activity ratio, pH 7.5:9.5 3.2 ±0.1 3.14±0.13 
kcat (s-1) 20.5±0.6 6.79±0.50 
KmF16P2 (µM) 1.39±0.11 1.42±0.18 
A0.5 (mM) 0.90±0.04 1.43±0.05 
Hill coefficient Mg2+ 1.82±0.16 1.95±0.10 
I0.5 (µM) 1.48±0.02 0.82±0.02a 
Hill coefficient AMP 1.90±0.04 1.45±0.03a 
Kb (µM) 1.83±0.23 1.67±0.31b 
KiF26P2 (µM) 0.22±0.03 0.033±0.005b 
 
 
a Data reported is for the high affinity site, IC50 for low affinity site is 3.07±0.40 mM. 
b The kinetic mechanism of F26P2 inhibition with respect to F16P2 fits a model for linear 
competitive inhibition: 
Vm/v=1 + Kb/B + (Kb/KiF26P2) (I/B) 
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Figure 13. AMP inhibition of wild-type and mutant FBPases. AMP titrations are of wild-
type (■), and Ile10Ala (●) FBPases in saturating F16P2 (20 µM) and an Mg2+ concentration 
equal to the Ka for Mg 2+ of each enzyme. 
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Figure 14. Mg2+cooperative behavior of Ile10-Ala mutant FBPase. Hill coefficient of 
Mg2+ is 2 in the absence of AMP (A); Mg2+ cooperativity is eliminated (Hill coefficient=1) 
when concentrations of AMP is 10 µM (B). 
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Figure 15. Structural elements important to allosteric regulation in the R-state of 
FBPase. 
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